128 related articles for article (PubMed ID: 10383086)
1. Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: an early marker for acute myocardial infarction.
Key G; Schreiber A; Feldbrügge R; McNeil CJ; Jørgensen P; Pelsers MM; Glatz JF; Spencer F
Clin Biochem; 1999 Apr; 32(3):229-31. PubMed ID: 10383086
[No Abstract] [Full Text] [Related]
2. An immunosensor for rapid estimation of the early heart infarction-marker FABP.
Key G; Schreiber A; Feldbrügge R; Glatz JF; Spener F
Acta Anaesthesiol Scand Suppl; 1997; 111():289-92. PubMed ID: 9421049
[No Abstract] [Full Text] [Related]
3. Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction.
Robers M; Van der Hulst FF; Fischer MA; Roos W; Salud CE; Eisenwiener HG; Glatz JF
Clin Chem; 1998 Jul; 44(7):1564-7. PubMed ID: 9665443
[No Abstract] [Full Text] [Related]
4. [Heart-type fatty acid-binding protein (H-FABP)].
Okamoto F; Sohmiya K; Tanaka T; Kitaura Y; Ohkaru Y
Nihon Rinsho; 1999 Aug; 57 Suppl():261-4. PubMed ID: 10503416
[No Abstract] [Full Text] [Related]
5. Fatty acid-binding protein as marker of muscle injury: experimental findings and clinical application.
Glatz JF; Van der Vusse GJ; Maessen JG; Van Dieijen-Visser MP; Hermens WT
Acta Anaesthesiol Scand Suppl; 1997; 111():292-4. PubMed ID: 9421050
[No Abstract] [Full Text] [Related]
6. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction.
Ghani F; Wu AH; Graff L; Petry C; Armstrong G; Prigent F; Brown M
Clin Chem; 2000 May; 46(5):718-9. PubMed ID: 10794758
[No Abstract] [Full Text] [Related]
7. Rapid estimation of myocardial infarct size.
van der Laarse A
Cardiovasc Res; 1999 Nov; 44(2):247-8. PubMed ID: 10690300
[No Abstract] [Full Text] [Related]
8. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein.
Wodzig KW; Pelsers MM; van der Vusse GJ; Roos W; Glatz JF
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():263-8. PubMed ID: 9158823
[TBL] [Abstract][Full Text] [Related]
9. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function.
Wodzig KW; Kragten JA; Hermens WT; Glatz JF; van Dieijen-Visser MP
Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):191-8. PubMed ID: 9127740
[TBL] [Abstract][Full Text] [Related]
10. A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry.
Robers M; Rensink IJ; Hack CE; Aarden LA; Reutelingsperger CP; Glatz JF; Hermens WT
Biophys J; 1999 May; 76(5):2769-76. PubMed ID: 10233092
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein.
Van Nieuwenhoven FA; Kleine AH; Wodzig WH; Hermens WT; Kragten HA; Maessen JG; Punt CD; Van Dieijen MP; Van der Vusse GJ; Glatz JF
Circulation; 1995 Nov; 92(10):2848-54. PubMed ID: 7586251
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid-binding protein and the early detection of acute myocardial infarction.
Glatz JF; van der Vusse GJ; Simoons ML; Kragten JA; van Dieijen-Visser MP; Hermens WT
Clin Chim Acta; 1998 Apr; 272(1):87-92. PubMed ID: 9581860
[TBL] [Abstract][Full Text] [Related]
13. Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates.
de Groot MJ; Wodzig KW; Simoons ML; Glatz JF; Hermens WT
Cardiovasc Res; 1999 Nov; 44(2):315-24. PubMed ID: 10690308
[TBL] [Abstract][Full Text] [Related]
14. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure.
Górski J; Hermens WT; Borawski J; Mysliwiec M; Glatz JF
Clin Chem; 1997 Jan; 43(1):193-5. PubMed ID: 8990251
[No Abstract] [Full Text] [Related]
15. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction.
Ishii J; Wang JH; Naruse H; Taga S; Kinoshita M; Kurokawa H; Iwase M; Kondo T; Nomura M; Nagamura Y; Watanabe Y; Hishida H; Tanaka T; Kawamura K
Clin Chem; 1997 Aug; 43(8 Pt 1):1372-8. PubMed ID: 9267316
[TBL] [Abstract][Full Text] [Related]
16. Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects.
Pelsers MM; Chapelle JP; Knapen M; Vermeer C; Muijtjens AM; Hermens WT; Glatz JF
Clin Chem; 1999 Mar; 45(3):441-3. PubMed ID: 10053065
[No Abstract] [Full Text] [Related]
17. Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients.
Fransen EJ; Maessen JG; Hermens WT; Glatz JF
Ann Thorac Surg; 1998 Jan; 65(1):48-53. PubMed ID: 9456094
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays.
Schreiber A; Specht B; Pelsers MM; Glatz JF; Börchers T; Spener F
Clin Chem Lab Med; 1998 May; 36(5):283-8. PubMed ID: 9676384
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins.
Wodzig KW; Kragten JA; Modrzejewski W; Górski J; van Dieijen-Visser MP; Glatz JF; Hermens WT
Clin Chim Acta; 1998 Apr; 272(2):209-23. PubMed ID: 9641361
[TBL] [Abstract][Full Text] [Related]
20. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
de Lemos JA; Antman EM; Morrow DA; Llevadot J; Giugliano RP; Coulter SA; Schuhwerk KC; Arslanian S; McCabe CH; Gibson CM; Rifai N
Clin Chim Acta; 2000 Aug; 298(1-2):85-97. PubMed ID: 10876006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
